Insider Selling: Spero Therapeutics (NASDAQ:SPRO) Director Sells 6,572 Shares of Stock
MarketBeat
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) Director Ankit Mahadevia sold 6,572 shares of the stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $1.97, for a total transaction of $12,946.84. Following the transaction, the director directly owned 703,294 shares in the company, valued at $1,385,489.18. The trade was a 0.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
NASDAQ:SPRO